Ariad v. Lilly (CAFC 2010)
Significant U.S. cases in 2010
Ariad v. Eli Lilly 560 F.3d 1366 (Fed. Cir. 2009) Written Description as a Function of Enablement N. Scott Pierce, Esq. Suffolk University Law School November.
September 21, 2006 DePaul University, Chicago, IL APLF- DePaul University College of Law 2006 Symposium on Intellectual Property Law.
07-Patent Disclosure 35 USC §112
Project Management
Experimental Data to Support Patentability of a Biological Pharmaceutical in the U.S. October 14, 2011 Presented by M. Paul Barker 1.
ENABLEMENT / WRITTEN DESCRIPTION PATENT PROSECUTION PRACTICE Presented at: Webb & Co. Rehovot, Israel Date: February 21, 2013 Presented by: Roy D. Gross.
Biotechnology/Chemical/Pharmaceutical Customer Partnership Topic: Biotechnology/Chemical/Pharmaceutical Customer Partnership Topic: Examining Issues When.
Examination Issues: Immunology Yvonne (Bonnie) Eyler Quality Assurance Specialist Technology Center 1600 USPTO (571) 272-0871 [email protected].
1 PATENT LAW Randy Canis CLASS 7 Disclosure and Enablement; ST: Drafting an Application.
Utility Requirement in Japan Makoto Ono, Ph.D. Anderson, Mori & Tomotsune E-mail: [email protected] Website:
